In pancreatic cancer, MET serves as both a marker and therapeutic target for CSCs,147 Additionally, the interaction between HGF/MET and tumor‐stromal cells helps to maintain the preferred glucose metabolism of pancreatic tumor stem cells.148. The gene discussed is MET; the disease is neoplasm.